Pain Management Nursing, Journal Year: 2020, Volume and Issue: 22(1), P. 15 - 20
Published: Nov. 1, 2020
Language: Английский
Pharmacological Research, Journal Year: 2020, Volume and Issue: 159, P. 104928 - 104928
Published: June 3, 2020
Language: Английский
Citations
47
Medical Cannabis and Cannabinoids, Journal Year: 2021, Volume and Issue: 4(1), P. 21 - 42
Published: Feb. 25, 2021
In 2017, a National Academies of Sciences, Engineering, and Medicine (NASEM) report comprehensively evaluated the body evidence regarding cannabis health effects through year 2016. The objectives this study are to identify map most recently (2016-2019) published literature across approved conditions for medical evaluate quality identified recent systematic reviews, following NASEM report. Following search from 5 databases consultation with experts, 11 were compilation evaluation: amyotrophic lateral sclerosis, autism, cancer, chronic noncancer pain, Crohn's disease, epilepsy, glaucoma, human immunodeficiency virus/AIDS, multiple sclerosis (MS), Parkinson's posttraumatic stress disorder. A total 198 studies included after screening condition-specific relevance imposing exclusion criteria: preclinical focus, non-English language, abstracts only, editorials/commentary, case studies/series, non-U.S. setting. Data extracted included: design type, outcome definition, intervention sample size, setting, reported effect size. Few completed randomized controlled trials (RCTs) identified. Studies classified as reviews graded using Assessing Methodological Quality Systematic Reviews-2 tool evidence. high-quality available conditions, exceptions MS (9 9 moderate/high quality; 2/9 indicating improved outcomes; 7/9 inconclusive), epilepsy (3 4 3 1 pain (12 13 7/13 6/7 inconclusive). Among RCTs, we few substantial rigor contribute base. However, there some which significant suggests that select dosage forms routes administration likely have favorable risk-benefit ratios (i.e., pain). requires more rigorous evaluation before consideration treatment option many necessary inform policy guidelines is currently insufficient conditions.
Language: Английский
Citations
39
Molecular Psychiatry, Journal Year: 2024, Volume and Issue: 29(7), P. 2021 - 2030
Published: Feb. 15, 2024
Language: Английский
Citations
6
Journal of Psychiatric Research, Journal Year: 2019, Volume and Issue: 111, P. 154 - 159
Published: Feb. 10, 2019
Language: Английский
Citations
31
International Journal of Mental Health and Addiction, Journal Year: 2025, Volume and Issue: unknown
Published: Jan. 7, 2025
Language: Английский
Citations
0
Current Addiction Reports, Journal Year: 2025, Volume and Issue: 12(1)
Published: March 18, 2025
Language: Английский
Citations
0
BMC Public Health, Journal Year: 2021, Volume and Issue: 21(1)
Published: May 1, 2021
Abstract Background The opioid overdose epidemic in Canada and the United States has become a public health crisis - with exponential increases opioid-related morbidity mortality. Recently, there been an increasing body of evidence focusing on opioid-sparing effects medical cannabis use (reduction reliance), as potential alternative treatment for chronic pain. objective this study is to assess effect authorization (oral morphine equivalent; OME) between 2013 2018 Alberta, Canada. Methods All adult patients defined users who were authorized by their care provider from propensity score matched non-authorized using controls. A total 5373 controls, all users. change weekly average OME drugs relative controls was measured. Interrupted time series (ITS) analyses used trend during 26 weeks (6 months) before 52 (1 year) after among Results Average age years 54% female. Patients low dose opioids (< 50 had increase per week (absolute 112.1 OME, 95% CI: 104.1 120.3); whereas higher (OME > 100), showed significant decrease over 6 months (− 435.5, − 596.8 274.2) compared Conclusions This short-term found that intermediate use, which dependent initial use. Greater observations changes appear be those high dosage 100); however, continued surveillance utilizing both warranted clinicians understand long-term benefits any harms ongoing
Language: Английский
Citations
23
Substance Use & Misuse, Journal Year: 2025, Volume and Issue: unknown, P. 1 - 10
Published: Feb. 2, 2025
Background: Research suggests that individuals who experience four or more adverse childhood experiences (ACEs) have increased rates of cannabis use. However, most prior research does not separate recreational and medical usage. Medical is used legally in many states to treat a variety health conditions, which are also associated with ACEs. Objectives: Therefore, we explore the extent users differ from whether use ACEs, poor health, disability. Accordingly, ask following questions: Are ACEs any when controlling for measures disability? use? associations between explained by and/or Results: Using 2019 BRFSS data, find significantly use, but disability fully account effect on Conclusions: We conclude practitioners screen status prescribing cannabis.
Language: Английский
Citations
0
Journal of Behavioral Medicine, Journal Year: 2020, Volume and Issue: 43(2), P. 174 - 184
Published: Feb. 18, 2020
Language: Английский
Citations
21
Drug and Alcohol Dependence, Journal Year: 2019, Volume and Issue: 204, P. 107456 - 107456
Published: Aug. 22, 2019
Language: Английский
Citations
22